>From the Anesthesiology and ICM Department, Baskent University Faculty of Medicine, Ankara, Turkey.
Exp Clin Transplant. 2021 Oct;19(10):1063-1068. doi: 10.6002/ect.2018.0067. Epub 2018 Oct 19.
We examined whether immediate tracheal extubation among pediatric liver transplant recipients was safe and feasible.
We retrospectively analyzed medical records of pediatric liver transplant recipients at Baskent University Hospital from January 2012 to December 2017. We grouped children who were extubated in the operating room versus those extubated in the intensive care unit.
In our study group of 81 pediatric patients, median age was 4 years (range, 4 mo to 16 y) and 44 (54%) were male. Immediate tracheal extubation in the operating room was performed in 39 patients (48%). Children who remained intubated (n = 42) had more frequent massive hemorrhage (14% vs 0%; P = .015), received larger amounts of packed red blood cells (19.3 vs 10.2 mL/kg; P < .001), and had higher serum lactate levels (9.0 vs 6.9 mmol/L; P = .001) intraoperatively. All children with open abdomens postoperatively remained intubated (n = 7). Patients extubated in the operating room received less vasopressors (1 [3%] vs 12 [29%]; P = .002) and antibiotics (11 [28%] vs 22 [52%]; P = 0.041) and developed infections less frequently postoperatively (3.0 [8%] vs 15.0 [36%]; P = .003). Children extubated in the operating room had shorter mean stay in the intensive care unit (2.0 vs 4.5 days; P < .001). Hospital mortality was higher in children who remained intubated (12% vs 0%; P = .026).
Immediate tracheal extubation was well tolerated in almost half of our patients and did not compromise their outcomes. Patients who remained intubated had longer intensive care unit stays and higher hospital mortalities. Therefore, we recommend immediate tracheal extubation in the operating room after pediatric liver transplant among those children without intraoperative requirements for massive blood transfusion, high-dose vasopressors, high serum lactate levels, and open abdomen.
研究小儿肝移植受者即刻气管拔管是否安全、可行。
回顾性分析 2012 年 1 月至 2017 年 12 月期间巴肯特大学医院小儿肝移植受者的病历。我们将在手术室拔管的患儿与在重症监护病房(ICU)拔管的患儿进行分组。
在我们的 81 例小儿患者研究组中,中位年龄为 4 岁(范围:4 个月至 16 岁),44 例(54%)为男性。39 例(48%)患儿在手术室即刻气管拔管。42 例仍插管患儿术中发生大量出血的频率更高(14%比 0%;P=0.015),接受的红细胞悬液量更大(19.3 比 10.2 mL/kg;P<0.001),血清乳酸水平更高(9.0 比 6.9 mmol/L;P=0.001)。所有术后腹部开放的患儿均仍插管(n=7)。手术室拔管患儿术中接受的血管加压素(1[3%]比 12[29%];P=0.002)和抗生素(11[28%]比 22[52%];P=0.041)更少,术后感染发生率更低(3.0[8%]比 15.0[36%];P=0.003)。手术室拔管患儿 ICU 住院时间更短(2.0 比 4.5 天;P<0.001)。仍插管患儿的院内死亡率更高(12%比 0%;P=0.026)。
在我们的患者中,近一半即刻气管拔管可耐受,且不会影响其结果。仍插管患儿 ICU 住院时间更长,院内死亡率更高。因此,我们建议对于术中无需大量输血、大剂量血管加压素、高血清乳酸水平和腹部开放的小儿肝移植受者,在手术室即刻气管拔管。